Scholarlink

Background <p>Ribosomes are the core machinery for cellular protein synthesis, and defects in their biogenesis have been confirmed to be closely associated with various diseases. Osteoarthritis (OA), one of the most common joint diseases worldwide, has a complex pathogenesis that remains incompletely elucidated. Traditional research has primarily focused on metabolic imbalances in articular cartilage and inflammatory responses. However, growing evidence suggests that dysregulated ribosome biogenesis may play a critical role in the pathogenesis of OA. Impaired ribosome biogenesis limits the protein translation capacity of chondrocytes and may participate in the initiation and progression of OA by modulating cellular metabolism and stress responses, indicating that OA could be considered an acquired ribosomopathy.</p> Main body <p>This review systematically summarizes the various factors involved in ribosome biogenesis and their impact on chondrocyte function and joint tissue homeostasis, with a particular focus on key molecules such as non-coding RNAs, ribosomal proteins, and translation regulators. By integrating the latest findings from in vivo and in vitro models, this work evaluates the potential therapeutic value of targeting ribosome biogenesis-related molecules for the treatment of OA.</p> Conclusion <p>In summary, in-depth investigation of the role of ribosome biogenesis in OA may not only provide new perspectives for elucidating its pathological mechanisms but also offer a theoretical foundation and potential targets for developing therapeutic strategies that modify the disease course.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ribosome biogenesis in osteoarthritis: mechanisms and therapeutic potential

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月18日

查看全文
  • Zewen Xu,
  • Zhiwei Pei,
  • Haobo Yang,
  • Shanjie Guo,
  • Qiang Li,
  • Liuchang Jiang,
  • Jing Wang,
  • Leipeng Wang,
  • Dexin Liu,
  • Xuanyin Chen,
  • Baoxin Zhang,
  • Ting Hao

摘要

Background

Ribosomes are the core machinery for cellular protein synthesis, and defects in their biogenesis have been confirmed to be closely associated with various diseases. Osteoarthritis (OA), one of the most common joint diseases worldwide, has a complex pathogenesis that remains incompletely elucidated. Traditional research has primarily focused on metabolic imbalances in articular cartilage and inflammatory responses. However, growing evidence suggests that dysregulated ribosome biogenesis may play a critical role in the pathogenesis of OA. Impaired ribosome biogenesis limits the protein translation capacity of chondrocytes and may participate in the initiation and progression of OA by modulating cellular metabolism and stress responses, indicating that OA could be considered an acquired ribosomopathy.

Main body

This review systematically summarizes the various factors involved in ribosome biogenesis and their impact on chondrocyte function and joint tissue homeostasis, with a particular focus on key molecules such as non-coding RNAs, ribosomal proteins, and translation regulators. By integrating the latest findings from in vivo and in vitro models, this work evaluates the potential therapeutic value of targeting ribosome biogenesis-related molecules for the treatment of OA.

Conclusion

In summary, in-depth investigation of the role of ribosome biogenesis in OA may not only provide new perspectives for elucidating its pathological mechanisms but also offer a theoretical foundation and potential targets for developing therapeutic strategies that modify the disease course.